ind
ユハン洋行は13日、慢性腎臓病(CKD)の新薬として開発中の候補物質「YH34180」の臨床第1相試験計画(IND)について、食品医薬品安全処から承認を受けたと発表した。YH34180は炎症反応と線維化の進行を抑制する経口低分子化合物だ。腎組織の損傷と機能低下を緩和し、慢性腎臓病の進行と合併症の発生を遅らせることを目標…
유한양행은 만성신장병 (CKD) 신약으로 개발 중인 후보물질 ‘YH34180′의 임상 1상 시험계획(IND)을 식품의약품안전처로부터 승인받았다고 13일 밝혔다. YH34180은 염증 반응과 섬유화 진행을 억제하는 경구용 저분자 화합물이다. 신장 조직의 손상과 기능 저하를 완화하고, 만성…
After a high-scoring T20I series, India and New Zealand will lock horns in the five-match ODI series starting November 4, Wednesday. Here’s how you can catch al…
New Zealand are set to host India for a two-match Test series, starting November 19, Thursday. Here’s all you need to know about the series.
Harbour BioMed announced on November 18, 2026 that China’s National Medical Products Administration had accepted the investigational new drug (IND) application …

Tenda 3mp Security Camera Dome IP Security Camera Indoor
$8.92
